# | Title | Journal | Year | Citations |
---|
1 | Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans | Biosafety and Health | 2021 | 193 |
2 | Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy | Biosafety and Health | 2020 | 188 |
3 | Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface | Biosafety and Health | 2020 | 162 |
4 | A strategy to prevent future epidemics similar to the 2019-nCoV outbreak | Biosafety and Health | 2020 | 102 |
5 | An update to monoclonal antibody as therapeutic option against COVID-19 | Biosafety and Health | 2021 | 97 |
6 | Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern China | Biosafety and Health | 2019 | 94 |
7 | Prevalence and transmission of mobilized colistin resistance (mcr) gene in bacteria common to animals and humans | Biosafety and Health | 2020 | 67 |
8 | A review of artificial intelligence applications for antimicrobial resistance | Biosafety and Health | 2021 | 65 |
9 | Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro | Biosafety and Health | 2020 | 60 |
10 | Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017 | Biosafety and Health | 2019 | 58 |
11 | Biosynthesis, bioactivity, biotoxicity and applications of antimicrobial peptides for human health | Biosafety and Health | 2022 | 38 |
12 | SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment | Biosafety and Health | 2020 | 35 |
13 | Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health | Biosafety and Health | 2022 | 33 |
14 | Advanced biosafety materials for prevention and theranostics of biosafety issues | Biosafety and Health | 2022 | 31 |
15 | Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020 | Biosafety and Health | 2020 | 26 |
16 | Clinical characteristics of patients diagnosed with COVID-19 in Beijing | Biosafety and Health | 2020 | 26 |
17 | Spatiotemporal patterns and trends of community transmission of the pandemic COVID-19 in South Asia: Bangladesh as a case study | Biosafety and Health | 2021 | 26 |
18 | Facing the 2020 pandemic: What does cyberbiosecurity want us to know to safeguard the future? | Biosafety and Health | 2021 | 25 |
19 | Yersinia pestis, a problem of the past and a re-emerging threat | Biosafety and Health | 2019 | 23 |
20 | Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment | Biosafety and Health | 2020 | 23 |
21 | Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition) | Biosafety and Health | 2020 | 22 |
22 | The impact of sample processing on the rapid antigen detection test for SARS-CoV-2: Virus inactivation, VTM selection, and sample preservation | Biosafety and Health | 2021 | 18 |
23 | Biosafety chemistry and biosafety materials: A new perspective to solve biosafety problems | Biosafety and Health | 2022 | 18 |
24 | Development of two multiplex real-time PCR assays for simultaneous detection and differentiation of monkeypox virus IIa, IIb, and I clades and the B.1 lineage | Biosafety and Health | 2022 | 17 |
25 | SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review | Biosafety and Health | 2021 | 16 |
26 | Expression pattern and function of SARS-CoV-2 receptor ACE2 | Biosafety and Health | 2021 | 16 |
27 | Convincing the confidence to conquer COVID-19: From epidemiological intervention to laboratory investigation | Biosafety and Health | 2020 | 16 |
28 | For a better world: Biosafety strategies to protect global health | Biosafety and Health | 2019 | 15 |
29 | Biosafety assessment of delivery systems for clinical nucleic acid therapeutics | Biosafety and Health | 2022 | 15 |
30 | Single virus tracking of Ebola virus entry through lipid rafts in living host cells | Biosafety and Health | 2020 | 14 |
31 | Laboratory biosafety in China: past, present, and future | Biosafety and Health | 2019 | 13 |
32 | Point-of-need molecular processing of biosamples using portable instrumentation to reduce turnaround time | Biosafety and Health | 2020 | 13 |
33 | Therapeutic implications of prion diseases | Biosafety and Health | 2021 | 13 |
34 | Estimation of the case fatality rate of COVID-19 epidemiological data in Nigeria using statistical regression analysis | Biosafety and Health | 2021 | 13 |
35 | The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control | Biosafety and Health | 2021 | 13 |
36 | Combination of chemistry and material science to overcome health problems | Biosafety and Health | 2022 | 13 |
37 | Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2 | Biosafety and Health | 2020 | 12 |
38 | The correlation of drug resistance and virulence in Mycobacterium tuberculosis | Biosafety and Health | 2020 | 12 |
39 | Finding the real COVID-19 case-fatality rates for SAARC countries | Biosafety and Health | 2021 | 12 |
40 | Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco | Biosafety and Health | 2021 | 12 |
41 | Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations | Biosafety and Health | 2021 | 12 |
42 | Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland | Biosafety and Health | 2020 | 11 |
43 | Case report for human infection with a highly pathogenic avian influenza A(H5N6) virus in Beijing, China 2019 | Biosafety and Health | 2020 | 11 |
44 | Molecular evolution and genetic diversity analysis of SFTS virus based on next-generation sequencing | Biosafety and Health | 2021 | 11 |
45 | Evaluating the effectiveness of control measures in multiple regions during the early phase of the COVID-19 pandemic in 2020 | Biosafety and Health | 2021 | 11 |
46 | Ti-MOF-based biosafety materials for efficient and long-life disinfection via synergistic photodynamic and photothermal effects | Biosafety and Health | 2022 | 11 |
47 | Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak | Biosafety and Health | 2022 | 11 |
48 | Evaluation of antibiotic resistance patterns in clinical isolates of Klebsiella pneumoniae in Bangladesh | Biosafety and Health | 2021 | 10 |
49 | Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system | Biosafety and Health | 2022 | 10 |
50 | The current emergence of monkeypox: The recurrence of another smallpox? | Biosafety and Health | 2022 | 10 |